Home / Products / Peptides / Details
video
Chinese Supplier Of High-Purity Tesamorelin (2mg/vial) Research-Grade Peptide

Chinese Supplier Of High-Purity Tesamorelin (2mg/vial) Research-Grade Peptide

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). Its peptide precursor consists of 44 amino acids—with a sequence identical to that of endogenous human growth hormone-releasing factor (GRF)—and is produced synthetically. As a GHRH receptor agonist, Tesamorelin is structurally optimized to offer greater stability and a longer half-life than natural GHRH, effectively resisting rapid degradation by the enzyme DPP-IV in the body. Originally developed by Theratechnologies under the trade name Egrifta, the compound received FDA approval in 2010, becoming the first and—to date—only drug approved for the treatment of excess abdominal fat in patients with HIV-associated lipodystrophy.

Product Introduction

**Clinical Applications**
The clinically approved use of Tesamorelin focuses on treating excess visceral fat in patients with HIV-associated lipodystrophy. Patients undergoing antiretroviral therapy often experience abnormal abdominal fat accumulation; Tesamorelin has been shown to selectively reduce visceral adipose tissue (VAT) while having minimal impact on peripheral subcutaneous fat. Additionally, clinical studies have observed improvements in lipid metabolism markers and reductions in triglyceride levels, along with potential positive effects on liver enzyme profiles.

In the realms of bodybuilding and athletics, Tesamorelin is used off-label, primarily for body fat management, body recomposition, and the optimization of growth hormone-related functions.

 

 

 

**Mechanism of Action**
Tesamorelin functions by mimicking endogenous GHRH. It binds to GHRH receptors on the somatotrophs (growth hormone-producing cells) of the anterior pituitary gland, stimulating the synthesis and pulsatile release of growth hormone (GH). GH subsequently acts on the liver and peripheral tissues to promote the production of insulin-like growth factor-1 (IGF-1). Together, GH and IGF-1 mediate various anabolic and lipolytic effects.

A clinical study involving healthy men demonstrated that daily subcutaneous injections of 2 mg of Tesamorelin for two weeks significantly elevated mean nocturnal GH levels, increased both the area under the GH pulse curve and basal secretion, and significantly raised IGF-1 levels. Importantly, the study found that while effectively boosting the activity of the GH/IGF-1 axis, Tesamorelin did not impair peripheral insulin-stimulated glucose uptake.

 

 

 

**Benefits in Bodybuilding**
The selective reduction of visceral fat represents the strongest clinical evidence for Tesamorelin's role in body recomposition. FDA review data indicate that during a 26-week treatment period, the Tesamorelin group experienced a significant reduction in visceral fat, whereas the placebo group did not show a similar effect. Trunk fat decreased by an average of 0.90 kg in the treatment group, while it increased by 0.28 kg in the placebo group. Meanwhile, the Tesamorelin group saw a 1.27 kg increase in lean body mass, whereas the placebo group experienced a decline.

For bodybuilders aiming for a lean physique, this pattern of body composition change-reducing fat while preserving muscle-holds practical value. Clinical studies also indicate that the reduction of visceral fat correlates with improvements in metabolic profiles, including better lipid levels and liver health markers.

It is important to note that clinical evidence for Tesamorelin primarily stems from studies on individuals with HIV-associated lipodystrophy; there is a lack of rigorous clinical trial data supporting its muscle-building efficacy in healthy athletes. Viewing Tesamorelin as a tool for body fat management rather than a direct "muscle-building drug" reflects a more accurate understanding of its effects.

 

 

 

Success Case
Clinical Research Data: A pooled analysis of two multicenter, double-blind, placebo-controlled Phase III trials showed that after 26 weeks of Tesamorelin treatment, patients experienced a significant reduction in visceral adipose tissue. On average, trunk fat decreased by 0.90 kg and lean body mass increased by 1.27 kg, while waist circumference decreased by approximately 1.5 cm more than in the placebo group.

Body Composition Improvement Case: A 49-year-old male user sought to reduce abdominal fat while preserving lean tissue. Following the intervention, his body weight increased by 0.5 kg, yet his waist circumference decreased by 0.75 inches. This pattern-stable or slightly increased weight accompanied by a smaller waist-indicates a favorable shift in body composition: fat loss alongside the preservation of lean tissue. His IGF-1 levels rose from the 33rd to the 42nd percentile, reflecting a moderate enhancement in GH/IGF-1 axis activity.

 

 

 

Why Choose Us
As a primary manufacturer specializing in the large-scale production of peptide raw materials, we offer the following core advantages:

Professional Production Facilities. We operate a specialized peptide production base that meets international standards. Equipped with comprehensive processing machinery-including systems for solid-phase synthesis, high-performance liquid chromatography (HPLC) purification, and freeze-drying-we possess the capacity to scale production from milligram-level R&D samples to kilogram-level commercial batches.

Stable Supply. Leveraging a mature supply chain management system and large-scale production capacity, we ensure consistent, reliable, high-volume supply, preventing delivery delays caused by insufficient capacity.

Purity Guaranteed. We employ rigorous purification processes and quality control standards to provide Tesamorelin products with purity levels of >95%, >98%, or higher, tailored to customer requirements. A comprehensive Certificate of Analysis (COA) accompanies every batch.

Consistent Quality and After-Sales Support. We implement a fully traceable quality management system covering everything from raw material procurement and synthesis to final product release. Our professional technical support team is ready to address quality-related inquiries and provide timely, reliable after-sales service.

We are dedicated to providing global customers with compliant, efficient, and stable peptide raw material solutions.

 

 

 

FAQ
Q: Where are your products manufactured?
A: Our products are manufactured in Shenzhen, China.
Q: What is the minimum order quantity (MOQ)?
A: The minimum order quantity is 10 vials/sets.
Q: How soon do you ship?
A: Orders for in-stock items are shipped within 24 hours.
Q: What purity levels do you offer?
A: Our standard purity is 99%.
Q: Which shipping carriers do you use?
A: We offer shipping via FedEx, DHL, UPS, and postal services.
Q: How long does shipping take?
A: Approximately 10–15 days.
Q: Do you provide COA and HPLC test reports?
A: Yes, we provide these; all products undergo professional testing before shipment.
Q: Do you offer OEM/private label services?
A: Yes, OEM/private label services are available, subject to minimum order quantity requirements.
Q: How is after-sales service handled?
A: If a quality issue attributable to our production is confirmed after the customer receives the goods, we offer free replacement or a refund. We uphold a pragmatic and responsible service philosophy, actively addressing and properly resolving any issues without evasion or excuses, fully safeguarding our customers' interests.
Q: What payment methods do you accept? A: Bank transfer, Bitcoin, TransferWise, and Xoom are supported.

Hot Tags: chinese supplier of high-purity tesamorelin (2mg/vial) research-grade peptide, China chinese supplier of high-purity tesamorelin (2mg/vial) research-grade peptide manufacturers, suppliers, factory

Send Inquiry

whatsapp

Phone

E-mail

Inquiry

Bag